---
title: 'Relationship between lipohypertrophy, glycemic control, and insulin dosing:
  a systematic meta-analysis'
date: '2024-01-12'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38215209/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240113170711&v=2.18.0
source: heidelberg[Affiliation]
description: Background Lipohypertrophy is a common complication in patients with
  diabetes receiving insulin therapy. There is a lack of consensus regarding how much
  lipohypertrophy affects diabetes management. Our study aimed to assess the potential
  correlation between lipohypertrophy and glycemic control, as well as insulin dosing
  in patients with diabetes. Methods We performed a systematic review followed by
  a meta-analysis to collect data about glycemic control and insulin dosing in diabetic
  ...
disable_comments: true
---
Background Lipohypertrophy is a common complication in patients with diabetes receiving insulin therapy. There is a lack of consensus regarding how much lipohypertrophy affects diabetes management. Our study aimed to assess the potential correlation between lipohypertrophy and glycemic control, as well as insulin dosing in patients with diabetes. Methods We performed a systematic review followed by a meta-analysis to collect data about glycemic control and insulin dosing in diabetic ...